【2h】

Cell biology of human vascular smooth muscle.

机译:人血管平滑肌的细胞生物学。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vascular smooth muscle is the cellular substrate of most significant arterial diseases. Restenosis after angioplasty and surgery mainly represents vascular smooth muscle reaction to trauma, a process which is also significant in the early stages of atherogenesis. Empirical approaches, based on findings in animal models of vascular injury, have notably failed to make any impact on human restenosis. We have developed and validated growth of the human VSMC in culture as a model of restenosis. Intimal hyperplastic lesions producing vascular restenosis contain cells that have reduced sensitivity to physiological growth inhibition by heparin in cell culture conditions, compared with cells from normal vascular tissue. Undiseased saphenous vein obtained from patients with intimal hyperplastic restenoses also contain cells that are relatively resistant to heparin inhibition. Arterial healing that progresses to restenosis may have distinct and fundamental differences at the cellular level from the normal process of arterial healing after injury.
机译:血管平滑肌是最重要的动脉疾病的细胞基质。血管成形术和手术后的再狭窄主要代表血管平滑肌对创伤的反应,这一过程在动脉粥样硬化的早期也很重要。基于血管损伤动物模型中发现的经验方法,显然未能对人类再狭窄产生任何影响。我们已经开发并验证了人类VSMC在文化中的生长,并将其作为再狭窄的模型。与来自正常血管组织的细胞相比,产生血管再狭窄的内膜增生性病变所包含的细胞在细胞培养条件下对肝素对生理生长抑制的敏感性降低。从患有内膜增生性再狭窄症的患者获得的未患病的大隐静脉还含有相对抗肝素抑制作用的细胞。进行性再狭窄的动脉愈合可能与损伤后的正常动脉愈合过程在细胞水平上具有明显的根本性差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号